Announcement on the placement of the actual controller and chairman of the company
2024 Semi-Annual Results Briefing Investor Relations Activity Record Form
Announcement on holding the 2024 semi-annual results briefing
Announcement on operating data for the second quarter of 2024
Announcement of Resolutions of the Fifth Meeting of the Third Board of Supervisors
Announcement of Resolutions of the Fifth Meeting of the Third Board of Directors
Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
CITIC Securities Co., Ltd.'s verification opinion on differentiated equity distribution matters of Jiangxi Tianxin Pharmaceutical Co., Ltd.
Company bylaws
2023 and 2024 First Quarter Results Briefing Investor Relations Activity Record Form
Notice on providing guarantees for holding subsidiaries
Announcement on holding the results briefing for the first quarter of 2023 and 2024
Announcement on short-term transactions and apologies due to misoperation by relatives of shareholders holding 5% or more of the shares
Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Jiangxi
CITIC Securities Co., Ltd.'s 2023 Continuous Supervision Work Site Inspection Report on Jiangxi Tianxin Pharmaceutical Co., Ltd.
CITIC Securities Co., Ltd.'s 2023 Continued Supervision Report on Jiangxi Tianxin Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Fourth Meeting of the Third Board of Directors
Announcement on operating data for the first quarter of 2024
Articles of Association
CITIC Securities Co., Ltd. inspection opinions on the use of idle funds raised by Jiangxi Tianxin Pharmaceutical Co., Ltd. for cash management
No Data
No Data